Robert Roswell Chai-Onn, EVP, GC and Corporate Secretary at Valeant Pharmaceuticals International, Inc. (VRX), bought 5,032 shares at $99.30 ($500K) on 2013-08-23, disclosed to the SEC on 2013-08-23.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| VRX | SELL | 2014-06-24 | $1.2M | — | Filing → |
| VRX | SELL | 2014-05-14 | $1.3M | — | Filing → |
| VRX | SELL | 2014-03-19 | $709K | — | Filing → |